These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7905376)

  • 21. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J; Mercer M
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and efficacy of a new preservative-free levocabastine ophthalmic solution (Levofree®) using the conjunctival provocation test].
    Allaire C; Siou-Mermet R; Bassols A
    J Fr Ophtalmol; 2012 Sep; 35(7):491-8. PubMed ID: 22498504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U; Bende M; Hedner J; Hedner T
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M; Pipkorn U
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of three antiallergic eyedrops in a specific conjunctival provocation test: mequitazine, levocabastine and dexamethasone].
    Richard C; Bibas P; Lablache-Combier M; Allaire C
    J Fr Ophtalmol; 2005 Mar; 28(3):244-50. PubMed ID: 15883488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.
    Mortemousque B; Jacquet A; Richard C; Depont F; Colin J; Moore N
    Br J Ophthalmol; 2004 Mar; 88(3):336-40. PubMed ID: 14977764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.
    Sabbah A; Marzetto M
    Curr Med Res Opin; 1998; 14(3):161-70. PubMed ID: 9787982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis. Emadine Study Group.
    Secchi A; Ciprandi G; Leonardi A; Deschenes J; Abelson MB
    Acta Ophthalmol Scand Suppl; 2000; (230):42-7. PubMed ID: 11057350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of levocabastine in conjunctival provocation studies.
    Janssens M
    Doc Ophthalmol; 1992; 82(4):341-51. PubMed ID: 1363980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The early efficacy of topical levocabastine in patients with allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Okamoto S; Nakagawa Y; Uchio E; Yokoi N; Fukushima A; Takamura E
    Allergol Int; 2006 Sep; 55(3):301-3. PubMed ID: 17075271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM; Vanden Bussche G
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.
    Wihl JA; Rudblad S; Kjellén H; Blychert LA
    Clin Exp Allergy; 1991 May; 21 Suppl 2():37-8. PubMed ID: 1680537
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
    Abelson MB; George MA; Smith LM
    Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
    Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
    Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB; Olsen AK
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C; Trinquand C; Bloch-Michel E
    Eur J Ophthalmol; 1998; 8(4):207-16. PubMed ID: 9891891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.